The local biotechnology industry is expected to grow rapidly in the coming years, but companies need to pair up with overseas partners to ensure growth and an international presence, industry experts said yesterday.
"We expect to see more than 25 percent growth in the local biotechnology industry over the next few years," said Johnsee Lee (
PHOTO: GEORGE TSORNG, TAIPEI TIMES
In 2001, there were 750 biotechnology companies in Taiwan generating US$3 billion in revenue. In the past two years combined, private companies invested more than NT$20 billion in biotechnology enterprises, Lee said.
"The industry has become three to four times bigger than it used to be, and we are seeing many new companies setting up," Lee said.
But the key for companies to continue to grow is finding overseas partners.
"Small companies need to collaborate and build alliances internationally," he said.
One of the venture capital companies working to bring overseas and Taiwanese companies together is the Taipei-based Cheng Xin Technology Development Corp (
"Part of what we do is tying up local companies with overseas partners for licensing and technology transfers," said Adeline Wong (
To encourage more local-international pair-ups, the government planned a themed month of biotechnology events for this month. Unfortunately SARS disrupted most of the international participation, forcing the organizers to postpone two core events to the fall.
The APEC Biotechnology Conference 2003 is now scheduled to take place on Sept. 28 and Sept. 29, and BioBusiness Asia 2003 will follow directly afterwards on Sept. 30 and Oct. 1. Twenty-four foreign biotech companies have been invited to present their business models to local hopefuls at the second event, Lee said yesterday.
The Bio Taiwan exhibition will start as planned today at the World Trade Center. The event is open only to trades, with no entry fee, everyday from 10:30am to 5pm until Sunday.
"The exhibition's 500 booths are all fully booked and we are expecting 100,000 visitors, making this the largest biotechnology event in Taiwan ever," Lee said.
One focus of the exhibition will be a SARS area, featuring companies that have worked on the genomic analysis and identification of the virus, diagnostic tools to detect the virus and possible vaccines and therapeutic treatments for sufferers.
At least one investor was looking forward to the exhibition.
"This is a very good opportunity to look at the better biotechnology companies in Taiwan all at once," said Willie Lin (
But one industry watcher was disappointed by the high proportion of government involvement in the exhibition.
"Of the 500 companies exhibiting, around 200 are government bodies or research institutes," said David Silver, director of Biotech-east.com, a Web site that promotes Taiwan's biotechnology and pharmaceutical industries. "I think it's a pity there aren't more private companies, but the SARS-related area will certainly be an interesting part of the event."
The government is banking on the success of the local biotechnology industry. Last May, President Chen Shui-bian (
But making money out of biotechnology may be a gamble.
"Sadly the investments so far have not been generating as much income as we had expected," Huang said. But Lin was much more upbeat.
"So far biotechnology companies are performing well compared with international standards. We are seeing pretty good results and are satisfied," he said.
BUSINESS UPDATE: The iPhone assembler said operations outlook is expected to show quarter-on-quarter and year-on-year growth for the second quarter Hon Hai Precision Industry Co (鴻海精密) yesterday reported strong growth in sales last month, potentially raising expectations for iPhone sales while artificial intelligence (AI)-related business booms. The company, which assembles the majority of Apple Inc’s smartphones, reported a 19.03 percent rise in monthly sales to NT$510.9 billion (US$15.78 billion), from NT$429.22 billion in the same period last year. On a monthly basis, sales rose 14.16 percent, it said. The company in a statement said that last month’s revenue was a record-breaking April performance. Hon Hai, known also as Foxconn Technology Group (富士康科技集團), assembles most iPhones, but the company is diversifying its business to
Apple Inc has been developing a homegrown chip to run artificial intelligence (AI) tools in data centers, although it is unclear if the semiconductor would ever be deployed, the Wall Street Journal reported on Monday. The effort would build on Apple’s previous efforts to make in-house chips, which run in its iPhones, Macs and other devices, according to the Journal, which cited unidentified people familiar with the matter. The server project is code-named ACDC (Apple Chips in Data Center) within the company, aiming to utilize Apple’s expertise in chip design for the company’s server infrastructure, the newspaper said. While this initiative has been
GlobalWafers Co (環球晶圓), the world’s No. 3 silicon wafer supplier, yesterday said that revenue would rise moderately in the second half of this year, driven primarily by robust demand for advanced wafers used in high-bandwidth memory (HBM) chips, a key component of artificial intelligence (AI) technology. “The first quarter is the lowest point of this cycle. The second half will be better than the first for the whole semiconductor industry and for GlobalWafers,” chairwoman Doris Hsu (徐秀蘭) said during an online investors’ conference. “HBM would definitely be the key growth driver in the second half,” Hsu said. “That is our big hope
The consumer price index (CPI) last month eased to 1.95 percent, below the central bank’s 2 percent target, as food and entertainment cost increases decelerated, helped by stable egg prices, the Directorate-General of Budget, Accounting and Statistics (DGBAS) said yesterday. The slowdown bucked predictions by policymakers and academics that inflationary pressures would build up following double-digit electricity rate hikes on April 1. “The latest CPI data came after the cost of eating out and rent grew moderately amid mixed international raw material prices,” DGBAS official Tsao Chih-hung (曹志弘) told a news conference in Taipei. The central bank in March raised interest rates by